Its latest quarterly revenue reached 33.00K, representing a year-over-year increase of 450.00%, while its net profit experienced a year-over-year increase of 58.83%.
The current valuation score of PAVmed Inc is 9.09. Its current P/E ratio is -0.02, which is -5033.84% below the recent high of 0.98 and -603476.26% above the recent low of -119.51.
The current earnings forecast score of PAVmed Inc is 8.00. The average price target is 36.50, with a high of 57.00 and a low of 16.00.
The current price momentum score of PAVmed Inc is 5.44. Currently, the stock price is trading between the resistance level at 5.32 and the support level at 3.37, making it suitable for range-bound swing trading.
The latest institutional shareholding proportion is 10.13%, representing a quarter-over-quarter increase of 2.00%.
The current risk assessment score of PAVmed Inc is 1.93. The company's beta value is 0.60. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.